Available: Print or CD
Handbook Generic Development
Master Formula & Manufacturing Processes
Title 17 - Part 2
Locum International Press.
Volume 17 - (Part 2)
Special Drug Development Series on
CD ROM
A Glimpse into the Future
This unique 10 part Series in the Handbook of Pharmaceutical Generic Development
provides in each of the series ten CDs consisting of ten
individual state-of-the-art real life commercial Master
Formulations together with the full manufacturing process. Title 17 Series
opens a window into the associations research and development product
pipeline. Allows researchers to view data and upgrade to the full Title
21 CMC (as described in 'special features').
All key processing and control details highlighted. Title 21 CMC are authoritatively
written in a practical hands-on manner by pharma industry experts to the
level of both FDA and MCA/EU commercially approved manufacturing processes,
highlighting the wide variety of technical documentation and product development
expertise.
Formula and processes in the series are currently in production in the
US or EU or both. Product and process specifications and quantities are
exact commercial amounts.
| 1. Diclofenac K 50 mg Tablets |
| 2. Felodipine 5, 10 mg Tablets |
| 3. Famotidine 10, 20, 40mg Tablets |
| 4. Piroxicam 10 + 20mg Tablets |
| 5. Clonazepan 0.5, 1.0, 2.0mg Tablets |
| 6. Atenolol 50, 100mg Tablets |
| 7. Terazosin HCl 1, 2, 5, 10mg Tablets |
| 8. Nabumatone 500 + 750mg Tablets |
| 9. Labetalol 100, 200, 300 mg Tablets (=Normadyne) |
| 10. Timolol Maleate Eye Drops |
Complete
CD series is available as a ten part volume series of 10 CDs with
illustrated
diagrams, graphs, tables in b/w/color.
ISBN:
0793-6643
| Price - Title 17 - Part 2 |
USD$
|
| Members per CD (Ext Plans) |
1599.00
|
| Non-members |
1999.00
|
 |
 |
 |
 |
 |
 |
| Ready-To-Go Link
| Handbook Series | Journal
Index | Specialized Journals
| Title
17 Calandar |
